Non-Current Assets
Operating Lease Right-of-Use Assets in Other Assets
Vertex Pharmaceuticals Operating Lease Right-of-Use Assets in Other Assets increased by 7.8% to $1.69B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 25.9%, from $1.34B to $1.69B. Over 5 years (FY 2020 to FY 2025), Operating Lease Right-of-Use Assets in Other Assets shows an upward trend with a 36.8% CAGR.
Analysis
StatementBalance Sheet Statement
SectionNon-Current Assets
First reportedQ4 2018
Last reportedQ1 2026May 5, 2026
Metric ID:
operating_lease_rou_assets_in_otherHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $316.87M | $312.34M | $330.30M | $329.00M | $318.30M | $342.70M | $347.40M | $336.30M | $324.30M | $310.50M | $293.60M | $312.90M | $569.80M | $1.40B | $1.36B | $1.34B | $1.31B | $1.59B | $1.56B | $1.69B |
| QoQ Change | — | -1.4% | +5.7% | -0.4% | -3.3% | +7.7% | +1.4% | -3.2% | -3.6% | -4.3% | -5.4% | +6.6% | +82.1% | +145.0% | -2.8% | -1.3% | -1.8% | +21.2% | -1.8% | +7.8% |
| YoY Change | — | — | — | — | +0.5% | +9.7% | +5.2% | +2.2% | +1.9% | -9.4% | -15.5% | -7.0% | +75.7% | +349.6% | +362.1% | +327.8% | +130.6% | +14.0% | +15.2% | +25.9% |
Range$293.60M – $1.69B
CAGR+42.2%
Avg YoY Growth+80.5%
Median YoY Growth+11.9%
Operating Lease Right-of-Use Assets in Other Assets at Other Companies
Frequently Asked Questions
- What is Vertex Pharmaceuticals's operating lease right-of-use assets in other assets?
- Vertex Pharmaceuticals (VRTX) reported operating lease right-of-use assets in other assets of $1.69B in Q1 2026.
- How has Vertex Pharmaceuticals's operating lease right-of-use assets in other assets changed year-over-year?
- Vertex Pharmaceuticals's operating lease right-of-use assets in other assets increased by 25.9% year-over-year, from $1.34B to $1.69B.
- What is the long-term trend for Vertex Pharmaceuticals's operating lease right-of-use assets in other assets?
- Over 5 years (2020 to 2025), Vertex Pharmaceuticals's operating lease right-of-use assets in other assets has grown at a 36.8% compound annual growth rate (CAGR), from $325.60M to $1.56B.